32 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Disease in HIV-AIDS ... (TB) • Disseminated ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Disease in HIV-AIDS ... (TB) • Disseminated ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... #management #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... and HPV test) is ... #Prevention #Treatment ... #management #opportunistic ... #pharmacology
Acute Retroviral Syndrome
Acute Retroviral Syndrome is the symptomatic presentation of acute human immunodeficiency virus infection

 •
Acute Retroviral ... Headache (45%) • Fever ... Presentations: • Opportunistic ... in which case opportunistic ... ) Treatment:
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
: • HIV • Recent ... are pulmonary • HIV ... : • Fever • Weight ... or IGRA HIV: ... • HIV-infected
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
: • HIV • Recent ... are pulmonary • HIV ... : • Fever • Weight ... or IGRA HIV: ... • HIV-infected
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
and Disease in HIV-AIDS ... be initiated in HIV-infected ... suggestive of HIV-related ... for HIV-related ... #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
in HIV-AIDS Preventing ... Treating Acute Infection ... #Prevention #Treatment ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
Simplex Virus (HSV ... HIV-AIDS Treating ... Mucocutaneous HSV ... #opportunistic ... #pharmacology
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
of HIV/AIDS patients ... • 10-20% of HIV-infected ... a decrease in HIV ... , HCV - Hepatic ... infection Treatment